UDCA, a novel strategy for preventing SARS-CoV-2 infection via FXR-mediated ACE2 downregulation

Acta Biochim Biophys Sin (Shanghai). 2023 Apr 20;55(5):885-887. doi: 10.3724/abbs.2023075.
No abstract available

MeSH terms

  • Angiotensin-Converting Enzyme 2
  • COVID-19* / prevention & control
  • Down-Regulation
  • Humans
  • SARS-CoV-2

Substances

  • Angiotensin-Converting Enzyme 2

Grants and funding

This work was supported by the grant from the Research Foundation of Education Bureau of Hunan Province, China (No. 19B490).